Skip to content
conftrace_
2024 EMNLP EMNLP 2024

Language Models are Surprisingly Fragile to Drug Names in Biomedical Benchmarks

AbstractMedical knowledge is context-dependent and requires consistent reasoning across various natural language expressions of semantically equivalent phrases. This is particularly crucial for drug names, where patients often use brand names like Advil or Tylenol instead of their generic equivalents. To study this, we create a new robustness dataset, RABBITS, to evaluate performance differences on medical benchmarks after swapping brand and generic drug names using physician expert annotations.We assess both open-source and API-based LLMs on MedQA and MedMCQA, revealing a consistent performance drop ranging from 1-10%. Furthermore, we identify a potential source of this fragility as the contamination of test data in widely used pre-training datasets.

🌉 Interdisciplinary Bridge - Artificial Intelligence and Healthcare & Medicine and Natural Language Processing

More from EMNLP 2024

All EMNLP 2024 papers →